Altimmune Share Price Today
(NASDAQ: ALT)

Name: Altimmune Share Price Today (NASDAQ: ALT) - Altimmune Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Altimmune share price is $5.72 & ₹497.46 as on 6 Mar 2025, 2.30 'hrs' IST

$5.72

▲

-0.24

(-4.03%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Altimmune share price in Dollar and Rupees. Guide to invest in Altimmune stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Altimmune, along with analyst recommendations, forecasts, and comprehensive financials.

Altimmune share price movements

Today's Low: $5.71
Today's High: $6.09
$5.72
0.17%
Downside
Day's Volatility :6.16%
Upside
6.0%
52 Weeks Low: $5.28
52 Weeks High: $11.77
$5.72
7.78%
Downside
52 Weeks Volatility :55.16%
Upside
51.38%

Altimmune (ALT) Returns

Period	Altimmune Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-34.79%	2.1%	0.0%
6 Months	-6.73%	-4.1%	0.0%
1 Year	-47.67%	2.2%	0.0%
3 Years	-15.94%	11.8%	-11.6%

Altimmune (ALT) Key Statistics

in dollars & INR

Previous Close	$5.96
Open	$5.94
Today's High	$6.085
Today's Low	$5.71
Market Capitalization	$426.0M
Today's Volume	$497.8K
52 Week High	$11.765
52 Week Low	$5.275
Revenue TTM	$20.0K
EBITDA	$-102.9M
Earnings Per Share (EPS)	$-1.57
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-59.86%

How to invest in Altimmune Stock (ALT) from India?

It is very easy for Indian residents to invest directly in Altimmune from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Altimmune stock in both Indian Rupees (INR) and US Dollars (USD). Search for Altimmune or ALT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Altimmune or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Altimmune shares which would translate to 0.152 fractional shares of Altimmune as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Altimmune, in just a few clicks!

Returns in Altimmune (ALT) for Indian investors in Rupees

The Altimmune stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Altimmune investment value today

Current value as on today

₹55,182

Returns

₹44,818

(-44.82%)

Returns from Altimmune Stock

₹49,781 (-49.78%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Altimmune (ALT)

-55%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Altimmune Stock from India on INDmoney has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Altimmune

BlackRock Inc
8.66%
Ameriprise Financial Inc
7.39%
Vanguard Group Inc
6.23%
State Street Corp
4.88%
TANG CAPITAL MANAGEMENT LLC
3.87%
Geode Capital Management, LLC
2.33%

Analyst Recommendation on Altimmune

Buy

75%Buy

25%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Altimmune(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Altimmune Stock (ALT)

What analysts predicted

Upside of 291.17%

Target:

$22.38

Current:

$5.72

Insights on Altimmune Stock (Ticker Symbol: ALT)

Price Movement
In the last 7 days, ALT stock has moved up by 0.3%
Decreasing Revenue
Revenue is down for the last 6 quarters, 362.0K → 5.0K (in $), with an average decrease of 35.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -22.84M → -23.18M (in $), with an average decrease of 1.5% per quarter
ALT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 109.3%
ALT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 61.7%

ALT Altimmune Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$5.8M	↓ 43.85%
Net Income	$-20.5M	↓ 47.61%
Net Profit Margin	-353.71%	↑ 25.45%

	FY20	Y/Y Change
Revenue	$8.2M	↑ 41.09%
Net Income	$-49.0M	↑ 139.01%
Net Profit Margin	-599.2%	↓ 245.49%

	FY21	Y/Y Change
Revenue	$4.4M	↓ 46.12%
Net Income	$-96.2M	↑ 96.09%
Net Profit Margin	-2.2K%	↓ 1581.38%

	FY22	Y/Y Change
Revenue	$-68.0K	↓ 101.54%
Net Income	$-84.7M	↓ 11.91%
Net Profit Margin	124.6K%	↑ 126758.52%

	FY23	Y/Y Change
Revenue	$426.0K	↓ 726.47%
Net Income	$-88.4M	↑ 4.41%
Net Profit Margin	-20.8K%	↓ 145340.15%

	FY24	Y/Y Change
Revenue	$20.0K	↓ 95.31%
Net Income	$-95.1M	↑ 7.48%
Net Profit Margin	-475.3K%	↓ 454532.79%

	Q3 FY23	Q/Q Change
Revenue	$362.0K	↑ 5933.33%
Net Income	$-20.7M	↑ 28.7%
Net Profit Margin	-5.7K%	↑ 261973.11%

	Q4 FY23	Q/Q Change
Revenue	$37.0K	↓ 89.78%
Net Income	$-31.6M	↑ 53.07%
Net Profit Margin	-85.5K%	↓ 79806.0%

	Q1 FY24	Q/Q Change
Revenue	$5.0K	↓ 86.49%
Net Income	$-24.4M	↓ 22.9%
Net Profit Margin	-487.9K%	↓ 402363.78%

	Q2 FY24	Q/Q Change
Revenue	$5.0K	↑ 0.0%
Net Income	$-24.6M	↑ 1.01%
Net Profit Margin	-492.8K%	↓ 4920.0%

	Q3 FY24	Q/Q Change
Revenue	$5.0K	↑ 0.0%
Net Income	$-22.8M	↓ 7.28%
Net Profit Margin	-456.9K%	↑ 35900.0%

	Q4 FY24	Q/Q Change
Revenue	$5.0K	↑ 0.0%
Net Income	$-23.2M	↑ 1.47%
Net Profit Margin	-463.6K%	↓ 6700.0%

	FY19	Y/Y Change
Profit	$-11.3M	↓ 209.03%

	FY20	Y/Y Change
Profit	$-25.3M	↑ 124.82%

	FY21	Y/Y Change
Profit	$3.9M	↓ 115.24%

	FY22	Y/Y Change
Profit	$-136.0K	↓ 103.52%

	FY23	Y/Y Change
Profit	$-51.0K	↓ 62.5%

	FY24	Y/Y Change
Profit	$20.0K	↓ 139.22%

	Q3 FY23	Q/Q Change
Profit	$-18.0M	↑ 36.08%

	Q4 FY23	Q/Q Change
Profit	$-1.9M	↓ 89.72%

	Q1 FY24	Q/Q Change
Profit	$-102.0K	↓ 94.5%

	Q2 FY24	Q/Q Change
Profit	$-56.0K	↓ 45.1%

	Q3 FY24	Q/Q Change
Profit	$5.0K	↓ 108.93%

	FY19	Y/Y Change
Operating Cash Flow	$-9.6M	↑ 2.27%
Investing Cash Flow	$-28.3M	↑ 2725.41%
Financing Cash Flow	$12.5M	↓ 61.43%

	FY20	Y/Y Change
Operating Cash Flow	$-34.4M	↑ 258.64%
Investing Cash Flow	$-72.1M	↑ 154.88%
Financing Cash Flow	$213.5M	↑ 1603.52%

	FY21	Y/Y Change
Operating Cash Flow	$-78.2M	↑ 127.19%
Investing Cash Flow	$87.5M	↓ 221.4%
Financing Cash Flow	$65.1M	↓ 69.51%

	FY22	Y/Y Change
Operating Cash Flow	$-62.6M	↓ 20.01%
Investing Cash Flow	$-73.4M	↓ 183.86%
Financing Cash Flow	$56.8M	↓ 12.78%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-20.5M	↑ 5.7%
Investing Cash Flow	$4.4M	↑ 10.41%
Financing Cash Flow	$588.0K	↓ 95.56%

Altimmune Technicals Summary

Sell

Neutral

Buy

Altimmune is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Altimmune (ALT) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Altimmune Inc	-10.24%	-6.73%	-47.67%	-15.94%	88.61%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Altimmune Inc	NA	NA	0.0	-1.19	-0.6	-0.37	NA	1.71
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Altimmune Inc	Buy	$426.0M	88.61%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Altimmune

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Organization	Altimmune
Employees	59
CEO	Dr. Vipin K. Garg Ph.D.
Industry	Commercial Services

Management People of Altimmune

Name	Title
Dr. Vipin K. Garg Ph.D.	President, CEO & Director
Dr. M. Scot Roberts Ph.D.	Chief Scientific Officer
Dr. Matthew Scott Harris AGAF, FCAP, M.D., MS	Chief Medical Officer
Mr. Gregory L. Weaver CPA, M.B.A.	Chief Financial Officer
Mr. Andrew Shutterly M.S.	Principal Financial & Accounting Officer and Corporate Controller
Mr. Bertrand Georges Ph.D.	Chief Technology Officer
Mr. Tony Blandin B.S.	Vice President of Quality & Compliance Management
Mr. Raymond M. Jordt M.B.A.	Chief Business Officer

Important FAQs about investing in ALT Stock from India :

What is Altimmune share price today?

Altimmune share price today stands at $5.72, Open: $5.94 ; Previous Close: $5.96 ; High: $6.09 ; Low: $5.71 ; 52 Week High: $11.77 ; 52 Week Low: $5.28.

The stock opens at $5.94, after a previous close of $5.96. The stock reached a daily high of $6.09 and a low of $5.71, with a 52-week high of $11.77 and a 52-week low of $5.28.

Can Indians buy Altimmune shares?

Yes, Indians can invest in the Altimmune (ALT) from India.

With INDmoney, you can buy Altimmune at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Altimmune at zero transaction cost.

How can I buy Altimmune shares from India?

It is very easy to buy Altimmune from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Altimmune (ALT) be purchased?

Yes, you can buy fractional shares of Altimmune with INDmoney app.

What are the documents required to start investing in Altimmune stocks?

To start investing in Altimmune, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.